T2 Biosystems, Inc

(NASDAQ:TTOO)

Latest On T2 Biosystems, Inc (TTOO):

Date/Time Type Description Signal Details
2023-05-30 21:00 ESTNewsT2 Biosystems up 31%, gets second largest order for sepsis-driven instrumentN/A
2023-05-23 18:33 ESTNewsT2 Biosystems GAAP EPS of -$1.32 misses by $0.07, revenue of $2.1M misses by $0.23MN/A
2023-05-23 18:33 ESTNewsT2 Biosystems files for FDA approval of T2Biothreat panelN/A
2023-05-23 18:33 ESTNewsT2 Biosystems sheds 28% on restructuring plans and Q1 missN/A
2023-05-23 18:33 ESTNewsT2 Biosystems, Inc. (TTOO) Q1 2023 Earnings Call TranscriptN/A
2023-03-24 01:25 ESTNewsT2 Biosystems affirms plans to add Candida Auris fungus detection to test panelN/A
2023-03-13 19:48 ESTNewsT2 Biosystems GAAP EPS of -$1.41 beats by $0.92, revenue of $5.48M beats by $0.08MN/A
2023-03-13 19:48 ESTNewsT2 Biosystems, Inc. (TTOO) Q4 2022 Earnings Call TranscriptN/A
2023-03-13 04:36 ESTNewsT2 Biosystems Q4 2022 Earnings PreviewN/A
2023-02-15 16:36 ESTNewsT2 Biosystems stock slides after pricing $12M securities offeringN/A
2023-02-14 01:24 ESTNewsT2 Biosystems falls 5% on public offeringN/A
2023-01-24 20:11 ESTNewsT2 Biosystems trades lower amid preliminary Q4 revenue resultsN/A
2022-12-28 18:41 ESTNewsT2 Biosystems innovative technology contract with Vizient extendedN/A
2022-11-11 00:13 ESTNewsT2 Biosystems GAAP EPS of -$2.95 misses by $0.90, revenue of $3.68M misses by $1.05MN/A
2022-11-11 00:13 ESTNewsT2 Biosystems, Inc. (TTOO) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 06:41 ESTNewsT2 Biosystems Q3 2022 Earnings PreviewN/A
2022-10-14 23:32 ESTNewsT2 Biosystems rises 14% after multiple new studies show rapid disease detectionN/A
2022-10-13 17:39 ESTNewsT2 Biosystems to develop, commercialize diagnostic test for early Lyme diseaseN/A
2022-10-12 10:52 ESTNewsT2 Biosystems stock dips on revised annual guidance, executes reverse stock splitN/A
2022-09-29 16:29 ESTNewsT2 Biosystems announces BARDA exercise of contract option 3 valued at $3.7MN/A
2022-09-23 00:23 ESTNewsT2 Biosystems stock rises ~17% after hours on Baltic region distribution agreementN/A
2022-08-27 03:47 ESTNewsT2 Biosystems' Survival RiddleN/A
2022-08-19 02:30 ESTNewsT2 Biosystems (TTOO) Investor Presentation - SlideshowN/A
2022-08-16 15:03 ESTNewsT2 Biosystems, Inc. (TTOO) CEO John Sperzel on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-15 22:39 ESTNewsT2 Biosystems GAAP EPS of -$0.10 misses by $0.01, revenue of $5.91M misses by $0.22MN/A
2022-08-15 22:39 ESTNewsT2 Biosystems Q2 results miss on top and bottom lines, but maintains 2022 outlookN/A
2022-08-13 02:05 ESTNewsT2 Biosystems Q2 2022 Earnings PreviewN/A
2022-08-10 06:34 ESTNewsT2 Biosystems stock rises ~9% premarket on plans to develop diagnostic test for monkeypoxN/A
2022-07-11 09:12 ESTNewsT2 Biosystems granted FDA Breakthrough Device Designation for Lyme disease testN/A
2022-07-07 19:29 ESTNewsT2 Biosystems cut to Neutral at BTIG on upcoming Q2 revenue miss, focus on cash burnN/A
2022-07-06 11:49 ESTNewsT2 Biosystems drops 4% on Q2 guidance and 2022 outlookN/A
2022-06-07 03:08 ESTNewsInovio Pharma, Bionano Genomics among health care stocks to join Russell Microcap Index; Tonix Pharma, iBio to leaveN/A
2022-05-21 19:14 ESTNewsT2 Biosystems stock rises after issuance of U.S. patent for direct detection of Lyme diseaseN/A
2022-05-07 09:08 ESTNewsT2 Biosystems stock falls 17% as Q1 net loss widens Y/YN/A
2022-05-06 08:54 ESTNewsT2 Biosystems GAAP EPS of -$0.10 misses by $0.02, revenue of $7.23M beats by $0.53MN/A
2022-05-06 08:54 ESTNewsT2 Biosystems, Inc. (TTOO) CEO John Sperzel on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-05 11:34 ESTNewsT2 Biosystems Q1 2022 Earnings PreviewN/A
2022-04-27 12:45 ESTNewsT2 Biosystems applies for FDA Breakthrough Device designation for its T2Biothreat PanelN/A
2022-03-31 19:48 ESTNewsT2 Biosystems announces additional funding of $4.4M for BARDA contractN/A
2022-03-08 02:57 ESTNewsA Roadmap To T2 Biosystems StoryN/A
2022-02-18 02:41 ESTNewsT2 Biosystems GAAP EPS of -$0.07 beats by $0.03, revenue of $6.98M beats by $1.58MN/A
2022-02-18 02:40 ESTNewsT2 Biosystems stock up 19% on earnings beat, 2022 outlookN/A
2022-02-18 02:40 ESTNewsT2 Biosystems, Inc. (TTOO) CEO John Sperzel on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-15 11:32 ESTNewsT2 Biosystems amends term loan agreement with CRGN/A
2022-02-03 18:34 ESTNewsT2 Biosystems' test detects Omicron subvariantsN/A
2022-01-11 19:03 ESTNewsT2 Biosystems sees Q4 revenue ahead of consensusN/A
2022-01-04 19:17 ESTNewsAccelerate Diagnostics And T2 Biosystems: Financial Woes Set To Continue In 2022N/A
2021-12-01 10:12 ESTNewsT2 Biosystems' T2SARS-CoV-2 Panel detects Omicron variantN/A
2021-11-05 14:36 ESTNewsT2 Biosystems, Inc. (TTOO) CEO John Sperzel on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-04 17:39 ESTNewsT2 Biosystems names Brett Giffin as chief commercial officerN/A

About T2 Biosystems, Inc (TTOO):

T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. It provides T2 Magnetic Resonance technology that enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument for detecting pathogens associated with sepsis and Lyme disease, and other applications, as well as T2Candida Panel that identifies the species of Candida, a fungal pathogen known to cause sepsis directly from whole blood. In addition, it provides T2Bacteria Panel, a multiplex diagnostic panel that detects various bacterial pathogens associated with sepsis; T2SARS-CoV-2 Panel, a COVID-19 molecular diagnostic test; and T2Resistance Panel for the early and sensitive detection of carbapenemase-resistance markers. Further, it develops T2Cauris Panel, a multi-drug resistant pathogen; and T2Lyme Panel for the detection of various strains of Lyme disease-causing bacteria. The company has collaboration agreements with Canon U.S. Life Sciences, Inc. to develop a diagnostic test panel to detect Lyme disease; and Allergan Sales, LLC to develop detection diagnostic test panel that adds one additional bacteria species to the existing T2Bacteria product candidate, as well as for testing drug resistance directly in whole blood. T2 Biosystems, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.

TTOO Quotes by TradingView

See Advanced Chart

General

  • Name T2 Biosystems, Inc
  • Symbol TTOO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDiagnostics & Research
  • Fiscal Year EndDecember
  • IPO Date2014-08-07
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.t2biosystems.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 13.12
  • Price/Book (Most Recent Quarter) 33.26
  • Enterprise Value Revenue 16.76
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.29
  • Next Year EPS Estimate -$0.24
  • Next Quarter EPS Estimate -$0.07
  • Profit Margin -258%
  • Operating Margin -228%
  • Return on Assets -48%
  • Revenue 18.13 million
  • Earnings Per Share -$1.28
  • Revenue Per Share $0.15
  • Gross Profit -20069000
  • Quarterly Earnings Growth 153.8%
View More

Highlights

  • Market Capitalization 266.54 million
  • EBITDA -47715000
  • PE Ratio -1.16
  • Analyst Target Price $2.83
  • Book Value Per Share $0.06
View More

Share Statistics

  • Shares Outstanding 148.08 million
  • Shares Float 140.6 million
  • % Held by Insiders 481%
  • % Held by Institutions 12.72%
  • Shares Short 9.42 million
  • Shares Short Prior Month 9.76 million
  • Short Ratio 0.47
  • Short % of Float 7%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • Beta 0.49
  • 52 Week High $3.79
  • 52 Week Low $0.34
  • 50 Day Moving Average 2.41
  • 200 Day Moving Average 1.6
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

T2 Biosystems, Inc (TTOO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

T2 Biosystems, Inc (TTOO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-04$N/A-$0.07-$0.086.67%
2020-09-302020-11-04$N/A-$0.08-$0.083.96%
2020-06-302020-08-11$N/A-$0.09-$0.1330.77%
2020-03-312020-05-05$2.55 million-$0.22-$0.248.33%
2019-12-312020-02-24$3.07 million-$0.30-$0.27-9.49%
2019-09-302019-11-18$1.68 million-$0.31-$0.322.36%
2019-06-302019-07-30$1.8 million-$0.35-$0.33-7.69%
2019-03-312019-05-02$1.79 million-$0.34-$0.31-8.97%
2018-12-312019-03-07$1.79 million-$0.35-$0.30-18.24%
2018-09-302018-11-01$2.47 million-$0.25-$0.3324.7%
2018-06-302018-08-02$3.93 million-$0.32-$0.344.48%
2018-03-312018-05-08$2.31 million-$0.36-$0.384%
2017-12-312018-03-19$1.66 million-$0.51-$0.44-15.91%
2017-09-302017-11-02$1.11 million-$0.45-$0.497.22%
2017-06-302017-08-03$956000-$0.50-$0.49-2.04%
2017-03-312017-05-02$941000-$0.48-$0.43-10.78%
2016-12-312017-03-15$909000-$0.48-$0.44-9.92%
2016-09-302016-11-01$1.09 million-$0.51-$0.533.41%
2016-06-302016-08-01$990000-$0.58-$0.56-4.19%
2016-03-312016-05-02$1.1 million-$0.55-$0.54-1.31%
2015-12-312016-02-16$1.01 million-$0.56-$0.594.55%
2015-09-302015-11-02$1.05 million-$0.57-$0.593.39%
2015-06-302015-08-04$565000-$0.54-$0.575.26%
2015-03-312015-05-05$188000-$0.53-$0.577.02%
2014-12-312015-02-17$119000-$0.45-$0.44-2.27%
2014-09-302014-11-04$N/A-$0.71-$0.57-24.56%
2014-06-302014-09-19$N/A-$6.35-$3.92-61.99%

T2 Biosystems, Inc (TTOO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

T2 Biosystems, Inc (TTOO) Chart:

T2 Biosystems, Inc (TTOO) News:

Below you will find a list of latest news for T2 Biosystems, Inc (TTOO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

T2 Biosystems, Inc (TTOO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-01-170.50.1CALL76 3670TRUE00
2025-01-1710.05CALL205 14930TRUE00
2025-01-171.50.12CALL1 190TRUE00
2025-01-170.50.4PUT1 20FALSE00
2025-01-1710PUT0 00FALSE00
2025-01-171.50PUT0 00FALSE00
2026-01-160.50.15CALL1095 62840TRUE00
2026-01-1610.05CALL32 2510TRUE00
2026-01-161.50.05CALL23 1450TRUE00
2026-01-160.50.4PUT15 270FALSE00
2026-01-1610PUT0 00FALSE00
2026-01-161.50PUT0 00FALSE00

Latest TTOO Trades:

Date Shares Price
Jun 13, 2022 5:50 PM EST100$0.1701
Jun 13, 2022 6:37 PM EST100$0.1701
Jun 13, 2022 6:37 PM EST100$0.1701
Jun 13, 2022 7:00 PM EST100$0.1701
Jun 13, 2022 7:16 PM EST100$0.1701

T2 Biosystems, Inc (TTOO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312520184030/0001193125-20-184030-index.htm
2018-10-23UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1492674/000000000018033146/0000000000-18-033146-index.htm
2018-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000076999318000385/0000769993-18-000385-index.htm
2018-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000076999318000386/0000769993-18-000386-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000076999319000004/0000769993-19-000004-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492674/000076999319000180/0000769993-19-000180-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000076999319000401/0000769993-19-000401-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000076999320000004/0000769993-20-000004-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000076999320000005/0000769993-20-000005-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492674/000076999320000125/0000769993-20-000125-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492674/000089542119000083/0000895421-19-000083-index.htm
2018-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924318018681/0000899243-18-018681-index.htm
2018-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924318018682/0000899243-18-018682-index.htm
2018-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924318018683/0000899243-18-018683-index.htm
2018-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924318018684/0000899243-18-018684-index.htm
2018-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924318018686/0000899243-18-018686-index.htm
2018-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924318020503/0000899243-18-020503-index.htm
2018-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924318020506/0000899243-18-020506-index.htm
2018-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924318020507/0000899243-18-020507-index.htm
2018-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924318020508/0000899243-18-020508-index.htm
2018-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924318020510/0000899243-18-020510-index.htm
2018-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924318024446/0000899243-18-024446-index.htm
2018-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924318024949/0000899243-18-024949-index.htm
2018-09-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924318025002/0000899243-18-025002-index.htm
2018-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924318028518/0000899243-18-028518-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319000293/0000899243-19-000293-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319000294/0000899243-19-000294-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319002638/0000899243-19-002638-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319002639/0000899243-19-002639-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319002640/0000899243-19-002640-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319003306/0000899243-19-003306-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319003310/0000899243-19-003310-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319003312/0000899243-19-003312-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319004672/0000899243-19-004672-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319004673/0000899243-19-004673-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319004674/0000899243-19-004674-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319004675/0000899243-19-004675-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319004676/0000899243-19-004676-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319016441/0000899243-19-016441-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319016448/0000899243-19-016448-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319016450/0000899243-19-016450-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319016456/0000899243-19-016456-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319016463/0000899243-19-016463-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319016819/0000899243-19-016819-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319016821/0000899243-19-016821-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319016822/0000899243-19-016822-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319016823/0000899243-19-016823-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319023459/0000899243-19-023459-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319023461/0000899243-19-023461-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319023465/0000899243-19-023465-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924319023537/0000899243-19-023537-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320000182/0000899243-20-000182-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320000185/0000899243-20-000185-index.htm
2020-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320000700/0000899243-20-000700-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320000995/0000899243-20-000995-index.htm
2020-01-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320001149/0000899243-20-001149-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320002026/0000899243-20-002026-index.htm
2020-01-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320002271/0000899243-20-002271-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320003298/0000899243-20-003298-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320003299/0000899243-20-003299-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320003302/0000899243-20-003302-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320004327/0000899243-20-004327-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320004332/0000899243-20-004332-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320005805/0000899243-20-005805-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320005806/0000899243-20-005806-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320005808/0000899243-20-005808-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320006668/0000899243-20-006668-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320008865/0000899243-20-008865-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320008866/0000899243-20-008866-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320008867/0000899243-20-008867-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320009493/0000899243-20-009493-index.htm
2020-06-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320017342/0000899243-20-017342-index.htm
2020-06-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320017343/0000899243-20-017343-index.htm
2020-06-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320017344/0000899243-20-017344-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320021769/0000899243-20-021769-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320021791/0000899243-20-021791-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320021793/0000899243-20-021793-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000089924320021797/0000899243-20-021797-index.htm
2019-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492674/000090266419000746/0000902664-19-000746-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492674/000090266420000826/0000902664-20-000826-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492674/000090571819000223/0000905718-19-000223-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492674/000091957419001448/0000919574-19-001448-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000095012320007901/0000950123-20-007901-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000095012320007909/0000950123-20-007909-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492674/000095012320007914/0000950123-20-007914-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312518191616/0001193125-18-191616-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312518240713/0001193125-18-240713-index.htm
2018-09-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312518269105/0001193125-18-269105-index.htm
2018-10-15S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1492674/000119312518299340/0001193125-18-299340-index.htm
2018-10-15S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1492674/000119312518299347/0001193125-18-299347-index.htm
2018-10-22CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1492674/000119312518304192/0001193125-18-304192-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312518319301/0001193125-18-319301-index.htm
2018-12-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312518347488/0001193125-18-347488-index.htm
2019-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1492674/000119312519040752/0001193125-19-040752-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312519072865/0001193125-19-072865-index.htm
2019-03-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312519081936/0001193125-19-081936-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1492674/000119312519122530/0001193125-19-122530-index.htm
2019-04-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1492674/000119312519122542/0001193125-19-122542-index.htm
2019-04-30DEFR14ARevised definitive proxy soliciting materialshttps://www.sec.gov/Archives/edgar/data/1492674/000119312519129234/0001193125-19-129234-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312519140936/0001193125-19-140936-index.htm
2019-05-31SDhttps://www.sec.gov/Archives/edgar/data/1492674/000119312519162569/0001193125-19-162569-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312519170912/0001193125-19-170912-index.htm
2019-07-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1492674/000119312519207002/0001193125-19-207002-index.htm
2019-07-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1492674/000119312519207011/0001193125-19-207011-index.htm
2019-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312519207110/0001193125-19-207110-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312519210939/0001193125-19-210939-index.htm
2019-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312519241968/0001193125-19-241968-index.htm
2019-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312519242066/0001193125-19-242066-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312519290892/0001193125-19-290892-index.htm
2019-11-13NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1492674/000119312519291010/0001193125-19-291010-index.htm
2019-11-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312519296088/0001193125-19-296088-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312520004752/0001193125-20-004752-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312520004754/0001193125-20-004754-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312520051831/0001193125-20-051831-index.htm
2020-03-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1492674/000119312520067410/0001193125-20-067410-index.htm
2020-03-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312520067413/0001193125-20-067413-index.htm
2020-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312520084070/0001193125-20-084070-index.htm
2020-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312520084288/0001193125-20-084288-index.htm
2020-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312520101433/0001193125-20-101433-index.htm
2020-04-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1492674/000119312520101443/0001193125-20-101443-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312520137518/0001193125-20-137518-index.htm
2020-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312520149358/0001193125-20-149358-index.htm
2020-05-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1492674/000119312520153099/0001193125-20-153099-index.htm
2020-05-29SDhttps://www.sec.gov/Archives/edgar/data/1492674/000119312520155663/0001193125-20-155663-index.htm
2020-06-15PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1492674/000119312520169315/0001193125-20-169315-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312520169351/0001193125-20-169351-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312520170945/0001193125-20-170945-index.htm
2020-06-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1492674/000119312520180893/0001193125-20-180893-index.htm
2020-06-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1492674/000119312520180906/0001193125-20-180906-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312520184030/0001193125-20-184030-index.htm
2020-07-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312520192314/0001193125-20-192314-index.htm
2020-08-05DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1492674/000119312520210044/0001193125-20-210044-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312520213399/0001193125-20-213399-index.htm
2020-08-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312520221875/0001193125-20-221875-index.htm
2020-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312520259187/0001193125-20-259187-index.htm
2020-10-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312520275430/0001193125-20-275430-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492674/000119312520287709/0001193125-20-287709-index.htm
2018-08-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492674/000156459018018960/0001564590-18-018960-index.htm
2018-11-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492674/000156459018026265/0001564590-18-026265-index.htm
2019-03-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1492674/000156459019007862/0001564590-19-007862-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492674/000156459019018534/0001564590-19-018534-index.htm
2019-08-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492674/000156459019028440/0001564590-19-028440-index.htm
2019-11-1810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492674/000156459019043775/0001564590-19-043775-index.htm
2019-11-2010-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492674/000156459019043898/0001564590-19-043898-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1492674/000156459020011217/0001564590-20-011217-index.htm
2020-04-2910-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1492674/000156459020019519/0001564590-20-019519-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492674/000156459020024073/0001564590-20-024073-index.htm
2020-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492674/000156459020039633/0001564590-20-039633-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492674/000156459020051270/0001564590-20-051270-index.htm
2018-10-24EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1492674/999999999518002710/9999999995-18-002710-index.htm
2018-10-16CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1492674/999999999718008638/9999999997-18-008638-index.htm
2019-09-06SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1492674/999999999719006730/9999999997-19-006730-index.htm
2019-09-12SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1492674/999999999719006813/9999999997-19-006813-index.htm
2020-02-06SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1492674/999999999720000571/9999999997-20-000571-index.htm
2020-02-28SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1492674/999999999720001069/9999999997-20-001069-index.htm

T2 Biosystems, Inc (TTOO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of T2 Biosystems, Inc (TTOO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 481%
Institutional Ownership: 1272%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-09-18Thomas J. LoweryChief Scientific OfficerBuy29,411.001.9657,645.56105,872.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318024949/0000899243-18-024949-index.htm
2018-09-18Thomas J. LoweryChief Scientific OfficerSell14,647.006.1489,932.58128,821.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318024949/0000899243-18-024949-index.htm
2018-09-18Thomas J. LoweryChief Scientific OfficerBuy36,235.002.4588,775.75142,107.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318024949/0000899243-18-024949-index.htm
2018-09-18Thomas J. LoweryChief Scientific OfficerBuy1,361.002.253,062.25143,468.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318024949/0000899243-18-024949-index.htm
2018-06-28John M SpragueChief Financial OfficerBuy17,292.0017,292.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318018683/0000899243-18-018683-index.htm
2019-06-11Michael J. CimaDirectorSell3,240.001.434,633.20213,178.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319016823/0000899243-19-016823-index.htm
2019-06-08Michael J. CimaDirectorBuy9,000.00216,418.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319016441/0000899243-19-016441-index.htm
2020-02-24John M SpragueChief Financial OfficerSell4,166.000.823,416.1222,222.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320006668/0000899243-20-006668-index.htm
2019-06-11JOHN W CUMMINGDirectorSell3,420.001.434,890.6023,580.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319016821/0000899243-19-016821-index.htm
2020-02-21John M SpragueChief Financial OfficerBuy10,000.0026,388.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320006668/0000899243-20-006668-index.htm
2019-06-08JOHN W CUMMINGDirectorBuy9,000.0027,000.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319016450/0000899243-19-016450-index.htm
2019-01-01SEYMOUR LIEBMANDirectorBuy9,708.0027,708.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319000294/0000899243-19-000294-index.htm
2018-06-28Alec BarclayOfficerBuy24,086.0034,979.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318018684/0000899243-18-018684-index.htm
2019-06-08SEYMOUR LIEBMANDirectorBuy9,000.0036,708.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319016448/0000899243-19-016448-index.htm
2018-09-11Alec BarclaySVP, OperationsBuy10,000.0037,155.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318024446/0000899243-18-024446-index.htm
2018-06-28John McDonoughPresident and CEOBuy108,696.00393,909.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318018681/0000899243-18-018681-index.htm
2017-11-30John McDonoughPresident & CEOBuy47,423.00406,604.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319002639/0000899243-19-002639-index.htm
2019-09-11Alec BarclaySVP, OperationsSell4,210.002.9212,293.2042,102.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319023537/0000899243-19-023537-index.htm
2018-06-08-04:00Adrian M JonesDirectorBuy9,000.004,224,894.00https://www.sec.gov/Archives/edgar/data/1492674/000076999318000386/0000769993-18-000386-index.htm
2018-06-08-04:00GOLDMAN SACHS GROUP INC10% Share HolderBuy9,000.004,224,894.00https://www.sec.gov/Archives/edgar/data/1492674/000076999318000385/0000769993-18-000385-index.htm
2019-01-01-05:00Adrian M JonesDirectorBuy13,289.004,236,453.00https://www.sec.gov/Archives/edgar/data/1492674/000076999319000004/0000769993-19-000004-index.htm
2020-01-02-05:00Adrian M JonesDirectorBuy34,188.004,270,641.00https://www.sec.gov/Archives/edgar/data/1492674/000076999320000004/0000769993-20-000004-index.htm
2020-01-02-05:00GOLDMAN SACHS GROUP INC10% Share HolderBuy34,188.004,270,641.00https://www.sec.gov/Archives/edgar/data/1492674/000076999320000005/0000769993-20-000005-index.htm
2018-09-18Thomas J. LoweryChief Scientific OfficerSell85,595.006.17528,121.1543,226.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318024949/0000899243-18-024949-index.htm
2018-09-19Thomas J. LoweryChief Scientific OfficerSell37,902.006.20234,992.4043,226.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318024949/0000899243-18-024949-index.htm
2018-09-20Thomas J. LoweryChief Scientific OfficerSell48,205.006.18297,906.9043,226.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318025002/0000899243-18-025002-index.htm
2019-02-01John McDonoughPresident & CEOSell9,443.003.4732,767.21439,688.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319002639/0000899243-19-002639-index.htm
2019-02-11John McDonoughPresident & CEOSell8,134.003.3627,330.24448,220.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319003306/0000899243-19-003306-index.htm
2019-01-31John McDonoughPresident & CEOSell4,895.003.3516,398.25449,131.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319002639/0000899243-19-002639-index.htm
2018-11-30John McDonoughPresident & CEOBuy47,422.00454,026.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319002639/0000899243-19-002639-index.htm
2019-02-09John McDonoughPresident & CEOBuy16,666.00456,354.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319003306/0000899243-19-003306-index.htm
2020-02-24Alec BarclaySVP, OperationsSell5,808.000.824,762.5646,294.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320005808/0000899243-20-005808-index.htm
2019-09-11Alec BarclaySVP, OperationsBuy10,000.0046,312.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319023537/0000899243-19-023537-index.htm
2020-01-08John McDonoughDirectorBuy16,666.00470,285.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320000995/0000899243-20-000995-index.htm
2020-02-03John McDonoughDirectorSell23,754.000.8820,903.52489,114.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320003299/0000899243-20-003299-index.htm
2020-01-01SEYMOUR LIEBMANDirectorBuy13,289.0050.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320000185/0000899243-20-000185-index.htm
2017-11-30Michael Terrence GibbsGeneral CounselBuy6,500.0050,687.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319002640/0000899243-19-002640-index.htm
2018-06-28Michael Terrence GibbsGeneral CounselBuy24,086.0050,791.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318018686/0000899243-18-018686-index.htm
2020-01-23John McDonoughDirectorSell57,417.001.1566,029.55512,868.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320002026/0000899243-20-002026-index.htm
2018-06-28Thomas J. LoweryChief Scientific OfficerBuy26,847.0051,947.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318018682/0000899243-18-018682-index.htm
2020-02-21Alec BarclaySVP, OperationsBuy10,000.0052,102.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320005808/0000899243-20-005808-index.htm
2018-11-06Stanley LapidusDirectorSell6,048.005.2931,993.9253,010.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318028518/0000899243-18-028518-index.htm
2019-06-11Stanley LapidusDirectorSell9,000.001.4412,960.0053,010.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319016822/0000899243-19-016822-index.htm
2018-09-19Thomas J. LoweryChief Scientific OfficerBuy10,403.002.2523,406.7553,629.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318024949/0000899243-18-024949-index.htm
2020-02-03Michael Terrence GibbsGeneral CounselSell3,283.000.882,889.0453,954.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320003302/0000899243-20-003302-index.htm
2019-02-01Michael Terrence GibbsGeneral CounselSell1,820.003.476,315.4054,428.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319002640/0000899243-19-002640-index.htm
2019-01-31Michael Terrence GibbsGeneral CounselSell939.003.353,145.6556,248.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319002640/0000899243-19-002640-index.htm
2020-02-11Michael Terrence GibbsGeneral CounselSell3,200.000.772,464.0056,587.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320004327/0000899243-20-004327-index.htm
2020-01-08John McDonoughDirectorBuy100,000.00570,285.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320000995/0000899243-20-000995-index.htm
2018-11-30Michael Terrence GibbsGeneral CounselBuy6,500.0057,187.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319002640/0000899243-19-002640-index.htm
2019-02-11Michael Terrence GibbsGeneral CounselSell3,005.003.3610,096.8057,237.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319003310/0000899243-19-003310-index.htm
2018-09-18Thomas J. LoweryChief Scientific OfficerBuy14,647.001.1616,990.5257,873.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318024949/0000899243-18-024949-index.htm
2017-11-30Thomas J. LoweryChief Scientific OfficerBuy15,000.0058,226.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319002638/0000899243-19-002638-index.htm
2018-11-06Stanley LapidusDirectorBuy27,058.001.1631,387.2859,058.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318028518/0000899243-18-028518-index.htm
2020-02-09Michael Terrence GibbsGeneral CounselBuy5,833.0059,787.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320004327/0000899243-20-004327-index.htm
2019-02-09Michael Terrence GibbsGeneral CounselBuy5,834.0060,262.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319003310/0000899243-19-003310-index.htm
2020-02-24Michael Terrence GibbsGeneral CounselSell5,808.000.824,762.5660,779.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320005806/0000899243-20-005806-index.htm
2019-06-08Stanley LapidusDirectorBuy9,000.0062,010.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319016463/0000899243-19-016463-index.htm
2020-02-03Thomas J. LoweryChief Scientific OfficerSell7,535.000.886,630.8062,169.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320003298/0000899243-20-003298-index.htm
2020-02-11Thomas J. LoweryChief Scientific OfficerSell3,200.000.772,464.0064,802.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320004332/0000899243-20-004332-index.htm
2020-02-21Michael Terrence GibbsGeneral CounselBuy10,000.0066,587.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320005806/0000899243-20-005806-index.htm
2019-02-01Thomas J. LoweryChief Scientific OfficerSell4,185.003.4714,521.9566,875.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319002638/0000899243-19-002638-index.htm
2020-02-09Thomas J. LoweryChief Scientific OfficerBuy5,833.0068,002.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320004332/0000899243-20-004332-index.htm
2020-02-24Thomas J. LoweryChief Scientific OfficerSell5,808.000.824,762.5668,994.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320005805/0000899243-20-005805-index.htm
2019-02-11Thomas J. LoweryChief Scientific OfficerSell3,005.003.3610,096.8069,704.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319003312/0000899243-19-003312-index.htm
2019-01-31Thomas J. LoweryChief Scientific OfficerSell2,166.003.357,256.1071,060.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319002638/0000899243-19-002638-index.htm
2019-02-09Thomas J. LoweryChief Scientific OfficerBuy5,834.0072,709.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319003312/0000899243-19-003312-index.htm
2018-11-30Thomas J. LoweryChief Scientific OfficerBuy15,000.0073,226.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319002638/0000899243-19-002638-index.htm
2020-02-21Thomas J. LoweryChief Scientific OfficerBuy10,000.0074,802.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320005805/0000899243-20-005805-index.htm
2018-09-20Thomas J. LoweryChief Scientific OfficerBuy31,603.003.22101,761.6674,829.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318025002/0000899243-18-025002-index.htm
2018-09-18Thomas J. LoweryChief Scientific OfficerBuy18,588.001.3124,350.2876,461.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318024949/0000899243-18-024949-index.htm
2019-01-01David B ElsbreeDirectorBuy9,708.0077,708.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319000293/0000899243-19-000293-index.htm
2018-09-19Thomas J. LoweryChief Scientific OfficerBuy27,499.003.2288,546.7881,128.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318024949/0000899243-18-024949-index.htm
2019-06-11David B ElsbreeDirectorSell3,600.001.445,184.0083,108.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319016819/0000899243-19-016819-index.htm
2019-06-08David B ElsbreeDirectorBuy9,000.0086,708.00https://www.sec.gov/Archives/edgar/data/1492674/000089924319016456/0000899243-19-016456-index.htm
2020-01-03David B ElsbreeDirectorSell5,316.001.166,166.5691,081.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320000700/0000899243-20-000700-index.htm
2018-09-20Thomas J. LoweryChief Scientific OfficerBuy16,602.003.2253,458.4491,431.00https://www.sec.gov/Archives/edgar/data/1492674/000089924318025002/0000899243-18-025002-index.htm
2020-01-01David B ElsbreeDirectorBuy13,289.0096,397.00https://www.sec.gov/Archives/edgar/data/1492674/000089924320000182/0000899243-20-000182-index.htm